This is a non-core endpoint: only basic statistics are computed.
Congenital and developmental myasthenia
DOID EFO MESH SNOMED Endpoint Browser
G6_CONDEVMYA
Myasthenia gravis: Myasthenia gravis (MG) is a rare, clinically heterogeneous, autoimmune disorder of the neuromuscular junction characterized by fatigable weakness of voluntary muscles.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
31
Check minimum number of events None
31
Include endpoints None
31
Remove individuals based on genotype QC
29
G6_CONDEVMYA
Control definitions
Control exclude
G6_MYONEU
Extra metadata
Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Congenital and developmental myasthenia
based on the number of shared cases.
Broader endpoints:
- Diseases of the myoneural junction and muscle
- Neurological diseases
- Neurological diseases
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Narrower endpoints:
None
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 29 | 19 | 10 |
| Unadjusted prevalence (%) | 0.01 | 0.01 | 0.01 |
| Mean age at first event (years) | 49.38 | 41.86 | 63.67 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: G6_CONDEVMYA – Congenital and developmental myasthenia
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Congenital and developmental myasthenia
↥Endpoint not on priority list, no data to show.